Nonalcoholic fatty liver disease (NALFD) is a leading cause of liver disease. Weight loss improves clinical features of NAFLD; however, maintenance of weight loss outside of investigational protocols is poor. The goals of this study were to characterize patterns and clinical predictors of long-term weight loss in ambulatory patients with NAFLD.). Baseline BMI and percent BMI change were secondary measures. Predictors of weight loss were determined using logistic regression., and the mean follow-up duration was 17.3±17.6 months. Most patients with NAFLD were in either overweight (26.1%) or class I obesity (30.5%) categories at baseline, while the prevalence of underweight and class III obesity was lower (0.2% and 15.4%, respectively). Overal...
p.364-368Background: Obesity is the most frequent risk factor associated with NAFLD, and bariatric s...
Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver dise...
Background and aim: Obesity is a risk factor for progression of fibrosis in chronic liver diseases s...
Background and Aims: Nonalcoholic fatty liver disease (NALFD) is a leading cause of liver disease. W...
BACKGROUND AND AIMS: Nonalcoholic fatty liver disease (NALFD) is a leading cause of liver disease. W...
Background and Aims: Nonalcoholic fatty liver disease (NALFD) is a leading cause of liver disease. W...
Overweight and obesity undoubtedly drive the prevalence of nonalcoholic fatty liver disease (NAFLD) ...
Importance: Nonalcoholic fatty liver disease (NAFLD) affects about 25% of adults worldwide and is...
Nonalcoholic fatty liver disease (NAFLD) is characterized by histological evidence of hepatic steato...
Background/aim Although weight loss is recommended for the treatment of nonalcoholic fatty liver dis...
Background: Referral to weight loss programmes is the only effective treatment for non-alcoholic fat...
Background: Obesity is the most frequent risk factor associated with NAFLD, and bariatric surgery (B...
Background: Preliminary evidence suggests that weight loss among obese has differential metabolic ef...
Purpose Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic synd...
Background: Clinical guidelines recommend weight loss to manage non-alcoholic fatty liver disease (N...
p.364-368Background: Obesity is the most frequent risk factor associated with NAFLD, and bariatric s...
Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver dise...
Background and aim: Obesity is a risk factor for progression of fibrosis in chronic liver diseases s...
Background and Aims: Nonalcoholic fatty liver disease (NALFD) is a leading cause of liver disease. W...
BACKGROUND AND AIMS: Nonalcoholic fatty liver disease (NALFD) is a leading cause of liver disease. W...
Background and Aims: Nonalcoholic fatty liver disease (NALFD) is a leading cause of liver disease. W...
Overweight and obesity undoubtedly drive the prevalence of nonalcoholic fatty liver disease (NAFLD) ...
Importance: Nonalcoholic fatty liver disease (NAFLD) affects about 25% of adults worldwide and is...
Nonalcoholic fatty liver disease (NAFLD) is characterized by histological evidence of hepatic steato...
Background/aim Although weight loss is recommended for the treatment of nonalcoholic fatty liver dis...
Background: Referral to weight loss programmes is the only effective treatment for non-alcoholic fat...
Background: Obesity is the most frequent risk factor associated with NAFLD, and bariatric surgery (B...
Background: Preliminary evidence suggests that weight loss among obese has differential metabolic ef...
Purpose Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic synd...
Background: Clinical guidelines recommend weight loss to manage non-alcoholic fatty liver disease (N...
p.364-368Background: Obesity is the most frequent risk factor associated with NAFLD, and bariatric s...
Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver dise...
Background and aim: Obesity is a risk factor for progression of fibrosis in chronic liver diseases s...